168 related articles for article (PubMed ID: 32624576)
1. Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer.
Yang L; Chen P; Zhang L; Wang L; Sun T; Zhou L; Li Z; Wu A
Br J Cancer; 2020 Sep; 123(6):973-981. PubMed ID: 32624576
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer.
Mao L; Wu J; Zhang Z; Mao L; Dong Y; He Z; Wang H; Chi K; Jiang Y; Lin D
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370781
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer.
Peng J; Li W; Fan W; Zhang R; Li X; Xiao B; Dong Y; Wan D; Pan Z; Lin J; Wu X
Cancer Cell Int; 2021 Oct; 21(1):554. PubMed ID: 34688293
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
5. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
[TBL] [Abstract][Full Text] [Related]
6. Prognostic markers for colorectal cancer: estimating ploidy and stroma.
Danielsen HE; Hveem TS; Domingo E; Pradhan M; Kleppe A; Syvertsen RA; Kostolomov I; Nesheim JA; Askautrud HA; Nesbakken A; Lothe RA; Svindland A; Shepherd N; Novelli M; Johnstone E; Tomlinson I; Kerr R; Kerr DJ
Ann Oncol; 2018 Mar; 29(3):616-623. PubMed ID: 29293881
[TBL] [Abstract][Full Text] [Related]
7. Chromatin organisation and cancer prognosis: a pan-cancer study.
Kleppe A; Albregtsen F; Vlatkovic L; Pradhan M; Nielsen B; Hveem TS; Askautrud HA; Kristensen GB; Nesbakken A; Trovik J; Wæhre H; Tomlinson I; Shepherd NA; Novelli M; Kerr DJ; Danielsen HE
Lancet Oncol; 2018 Mar; 19(3):356-369. PubMed ID: 29402700
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE
Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
10. Automated assessment of DNA ploidy, chromatin organization, and stroma fraction to predict prognosis and adjuvant therapy response in patients with stage II colorectal carcinoma.
Zhao Z; Zhang X; Li Z; Gao Y; Guan X; Jiang Z; Liu Z; Yang M; Chen H; Ma X; Yang R; Lu Z; Liu H; Yang L; Wu A; Zou S; Wang X
Am J Cancer Res; 2021; 11(12):6119-6132. PubMed ID: 35018246
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
Sinicrope FA; Hart J; Michelassi F; Lee JJ
Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer.
Ersvaer E; Hveem TS; Vlatkovic L; Brennhovd B; Kleppe A; Tobin KAR; Pradhan M; Cyll K; Waehre H; Kerr DJ; Danielsen HE
Int J Cancer; 2020 Aug; 147(4):1228-1234. PubMed ID: 31846064
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.
Li Y; Liao L; Kong L; Jiang W; Tang J; Han K; Hou Z; Zhang C; Zhou C; Zhang L; Sui Q; Xiao B; Mei W; Xu Y; Yu J; Hong Z; Pan Z; Ding P
Clin Transl Oncol; 2023 Jan; 25(1):218-225. PubMed ID: 36076121
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
16. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
17. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
18. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
19. Deficient mismatch repair as a prognostic marker in stage II colon cancer patients.
Gkekas I; Novotny J; Fabian P; Nemecek R; Palmqvist R; Strigård K; Pecen L; Svoboda T; Gurlich R; Gunnarsson U
Eur J Surg Oncol; 2019 Oct; 45(10):1854-1861. PubMed ID: 31186203
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
